Ultra-low dose radiotherapy for salivary MALT lymphoma: lessons from small numbers
Authors:
- 21 November 2019
- journal article
- editorial
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 61 (1) , 4-6
Abstract
(2019). Ultra-low dose radiotherapy for salivary MALT lymphoma: lessons from small numbers. Leukemia & Lymphoma. Ahead of Print.Keywords
This publication has 17 references indexed in Scilit:
- Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary functionLeukemia & Lymphoma, 2019
- Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatmentInternational Journal of Dental Hygiene, 2018
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41)The Oncologist, 2015
- Long-Term Outcomes and Patterns of Relapse of Early-Stage Extranodal Marginal Zone Lymphoma Treated With Radiation Therapy With Curative IntentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Patient reported outcome measures in practiceBMJ, 2015
- Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damageTherapeutics and Clinical Risk Management, 2015
- Patient-reported Outcomes (PROs)Medical Care, 2013
- Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy in Advanced Lymphoma: A Phase II StudyClinical Lymphoma Myeloma and Leukemia, 2008
- Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical OutcomeJournal of Clinical Oncology, 2003
- Stage I and II malt lymphoma: results of treatment with radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001